Diagnos President and CEO André Larente expressed gratitude for CED's support, highlighting the company's recognition as a key asset in the Canadian economy. CED, focused on fostering economic development in Quebec, supports SMEs in becoming more innovative and competitive. Diagnos's CARA tool enhances retinal image analysis, providing a cost-effective solution for real-time patient screening. Further details are available in the press release from CED dated January 29, 2025.
Key takeaways:
- DIAGNOS Inc. received a financial contribution of up to CA$400,000 from the Canada Economic Development for Quebec Regions organization to implement an international marketing strategy for its CARA project.
- The financial assistance agreement specifies that CED will cover 50% of eligible expenses related to the project, with repayment starting 24 months after the project's end and spanning over 60 months without interest.
- DIAGNOS is recognized for its FLAIRE AI platform, which aids in the early detection of critical health issues, and its CARA tool provides cost-effective real-time screening of retinal images.
- CED is focused on fostering business start-ups and growth in Quebec, aiming to make enterprises more innovative, productive, and competitive to boost economic well-being in the region.